Related Experiment Videos

Approach to febrile neutropenia in the general paediatric setting

Lillian Sung1, Donna L Johnston

  • 1Division of Hematology/Oncology and Program in Population Health Sciences, The Hospital for Sick Children, Toronto.

Paediatrics & Child Health
|November 26, 2008
PubMed

Insights

Febrile neutropenia in children requires prompt antibiotic treatment, especially in cancer patients. Management outside the oncology setting depends on the underlying condition and infection risk.

Area of Science:

  • Pediatrics
  • Oncology
  • Infectious Diseases

Background:

  • Febrile neutropenia is a frequent complication in pediatric cancer patients.
  • It can also occur in children without cancer, presenting unique management challenges.

Purpose of the Study:

  • To provide a general pediatric overview of febrile neutropenia.
  • To outline current management principles for febrile neutropenia in both cancer and non-cancer settings.

Main Methods:

  • Review of existing literature and clinical guidelines.
  • Discussion of management strategies based on patient population (cancer vs. non-cancer).

Main Results:

  • For pediatric cancer patients with febrile neutropenia, prompt empirical antibiotics are recommended.
  • Outpatient management for cancer-related febrile neutropenia lacks sufficient evidence.
  • Management in non-cancer settings requires consideration of the underlying condition and risk of invasive infection.

Conclusions:

  • Standardized management for febrile neutropenia in pediatric cancer patients remains crucial.
  • Further research is needed to establish evidence-based guidelines for febrile neutropenia in non-cancer pediatric populations.
  • Individualized assessment is key for managing febrile neutropenia outside the oncology context.

Keywords:
CancerChildrenEmpirical antibioticsFebrile neutropenia

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...